NCT00112320

Brief Summary

Repair of tetralogy of Fallot (TOF), the most common form of cyanotic congenital heart disease, usually involves surgery on the outflow of the right ventricle (RV) and the pulmonary valve in order to relieve obstruction to blood flow from the RV to the lungs. This procedure often leads to regurgitation (leakage) of the pulmonary valve, which puts the burden of handling a larger than normal amount of blood flow on the RV. Over the years, that extra burden leads to enlargement of the RV and to a decrease in its function. Treatment often includes surgical insertion or replacement of a new pulmonary valve. Replacement of the damaged pulmonary valve aims to minimize the leakage and help the RV function better. This study is designed to compare two methods of how the operation (called pulmonary valve replacement \[PVR\]) is performed. In the first method, a new valve is inserted and only the area of the old valve is operated on; this is the standard PVR. The second method involves inserting the new valve in the same way as the standard method but, in addition, areas of the right ventricular wall that are scarred and not functioning well are removed (PVR plus right ventricular remodeling). This study will evaluate which method is more effective based on the size and function of the RV measured by cardiac magnetic resonance imaging (CMR) six months following surgery, as compared to its size and function before the operation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
68

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2004

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2004

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

June 1, 2005

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 2, 2005

Completed
6.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2011

Completed
Last Updated

December 4, 2012

Status Verified

December 1, 2012

Enrollment Period

7.3 years

First QC Date

June 1, 2005

Last Update Submit

December 3, 2012

Conditions

Keywords

Pulmonary Valve RegurgitationRight Ventricular DysfunctionHeart Diseases

Outcome Measures

Primary Outcomes (1)

  • Changes in ventricular mechanics compared with the preoperative ventricular mechanics

    Measured at 6 months

Secondary Outcomes (1)

  • Incidence of one or more postoperative adverse events

    Measured at 6 months

Study Arms (2)

1

ACTIVE COMPARATOR

Standard PVR

Procedure: Standard PVR

2

EXPERIMENTAL

PVR plus RV remodeling

Procedure: PVR plus RV remodeling

Interventions

PVR and surgical RV remodeling, which includes bioprosthetic pulmonary valve insertion and resection of akinetic scarred areas on the anterior RV wall to reduce RV volume

2
Standard PVRPROCEDURE

PVR alone, which includes bioprosthetic pulmonary valve insertion and, when present, resection of right ventricular outflow tract (RVOT) aneurysm

1

Eligibility Criteria

Age10 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Undergoing PVR to repair TOF at Children's Hospital Boston
  • Pulmonary regurgitation fraction greater than or equal to 25% (measured by CMR) and two or more of the following criteria:
  • RV end-diastolic volume index greater than or equal to 150 ml/m2 (Z score greater than 5)
  • RV end-systolic volume index greater than or equal to 70 ml/m2
  • LV end-diastolic volume index less than or equal to 65 ml/m2
  • RV ejection fraction less than 45%
  • RVOT aneurysm
  • Clinical criteria: exercise intolerance, symptoms and signs of heart failure, and use of cardiac medications

You may not qualify if:

  • Presence of either severe RV outflow tract obstruction (defined as peak-to-peak systolic gradient of greater than or equal to 60 mm Hg by cardiac catheterization) or severe RV hypertension at systemic or higher level
  • Additional sources of RV volume overload other than PR and tricuspid valve regurgitation
  • Contraindications to CMR

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Cardiology, Children's Hospital Boston

Boston, Massachusetts, 02115, United States

Location

Related Publications (1)

  • Geva T, Gauvreau K, Powell AJ, Cecchin F, Rhodes J, Geva J, del Nido P. Randomized trial of pulmonary valve replacement with and without right ventricular remodeling surgery. Circulation. 2010 Sep 14;122(11 Suppl):S201-8. doi: 10.1161/CIRCULATIONAHA.110.951178.

MeSH Terms

Conditions

Tetralogy of FallotPulmonary Valve InsufficiencyVentricular Dysfunction, RightHeart Diseases

Condition Hierarchy (Ancestors)

Heart Defects, CongenitalCardiovascular AbnormalitiesCardiovascular DiseasesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesHeart Valve DiseasesVentricular Dysfunction

Study Officials

  • Tal Geva, MD

    Boston Children's Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study coordinator

Study Record Dates

First Submitted

June 1, 2005

First Posted

June 2, 2005

Study Start

April 1, 2004

Primary Completion

August 1, 2011

Study Completion

August 1, 2011

Last Updated

December 4, 2012

Record last verified: 2012-12

Locations